TI  - Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: Recommendations of the advisory committee on immunization practices (acip)
PT  - JOUR
DP  - 2013
TA  - JAMA
pages = {334-336},
VI  - 309
IP  - 4
AID  - 10.1001/jama.2012.31377 [doi]
4100  - http://dx.doi.org/10.1001/jama.2012.31377
SO  - JAMA January 23, 2013 309(4):334